Dickinson

Life Science Equipment Market to Achieve $92.21 Billion Valuation by 2030, Driven by Advancements in Genomics and Proteomics - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 7, 2023
Genetics, Science, Health, Other Science, Shimadzu, Food safety, Sartorius AG, Biotechnology, Prevalence, Research, ChromeOS, PerkinElmer, Bruker, Growth, Genomics, Danaher Corporation, Dickinson, SE, Agilent Technologies, Proteomics, Waters Corporation, Automation, Fine chemical

The "Life Science Equipment Market by Technology, End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Life Science Equipment Market by Technology, End User - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global life science equipment market is on a growth trajectory and is expected to reach a valuation of $92.21 billion by 2030, with a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030.
  • Pharmaceutical and Biotechnology Dominance: Among end users, the pharmaceutical and biotechnology industry segment is estimated to account for the largest share of the life science equipment market in 2023.
  • Regional Insights: In 2023, North America is anticipated to hold the largest share of the life science equipment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Pharmacy Automation Devices Market to Achieve $5.52 Billion in 2023, Fueled by Innovation and Waste Reduction Solutions

Retrieved on: 
Wednesday, October 18, 2023
Emergency, Acquisition, Health, Geography, Growth, Medicine, Dickinson, Pharmacy, Robotics, Generic drug, Medical device, Video game, USD

The pharmacy automation devices market research report provides comprehensive statistics, encompassing global market size, regional shares, competitive analysis, detailed market segments, trends, and growth opportunities.

Key Points: 
  • The pharmacy automation devices market research report provides comprehensive statistics, encompassing global market size, regional shares, competitive analysis, detailed market segments, trends, and growth opportunities.
  • Product innovation is a prominent trend in the pharmacy automation devices market.
  • The growth of the pharmacy automation devices market is propelled by the rising issue of medicine wastage, including expired, unused, spilled, and contaminated pharmaceuticals.
  • Global Pharmacy Automation Devices Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Prefilled Syringes Market Size & Share Analysis Report 2023 - Global Growth Trends & Forecasts to 2028 Featuring Key Players - BD & Co, Terumo, Gerresheimer, SCHOTT, & West Pharmaceutical Services - ResearchAndMarkets.com

Retrieved on: 
Friday, September 22, 2023
Infectious Diseases, COVID-19, Health, Pharmaceutical, Medical Supplies, Vaccine, Conditional sentence, Insulin, MDI, Prevalence, Diabetes, Vaccination, World Health Organization's response to the COVID-19 pandemic, Diabetes Care, IDF, International Diabetes Federation, Messenger, USD, Dickinson, COVID-19 vaccine, Medtronic, Patient, Novo Nordisk, Growth, NewCo, Ageing, NHS, FDA, SCHOTT, Safety, Glass, Rheumatoid arthritis, BD, Syringe, Pharmaceutical industry

The "Prefilled Syringes Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Prefilled Syringes Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's offering.
  • Notable companies operating in the prefilled syringes market include Becton, Dickinson, and Company, Terumo Corporation, Gerresheimer AG, SCHOTT, West Pharmaceutical Services, Inc., and West Pharmaceutical Services, Inc., among others.
  • The global prefilled syringes market experienced a positive impact from the COVID-19 pandemic, primarily due to the potential use of prefilled syringes for COVID-19 vaccines.
  • This transition from vials to prefilled syringes was aimed at addressing the cost and complexity of vaccine administration.

Environmental and Indigenous Rights Advocate Tara Houska to Discuss Her Groundbreaking Advocacy Work During Public Talk at Dickinson College

Retrieved on: 
Tuesday, September 19, 2023
Couchiching First Nation, Barack Obama, All We Can Save, Dakota Access Pipeline, Tara Houska, Vogue, Woman, Advocate, Movement, Houska, Organization, Dickinson, Native Americans, Publication, The New York Times, Dickinson College, Stop Line 3 protests, Empathy

CARLISLE, Pa., Sept. 19, 2023 /PRNewswire/ -- Advocate for environmental and Indigenous rights Tara Houska will discuss her work as a tribal attorney, land defender and founder of the Giniw Collective during a special event at Dickinson College.

Key Points: 
  • CARLISLE, Pa., Sept. 19, 2023 /PRNewswire/ -- Advocate for environmental and Indigenous rights Tara Houska will discuss her work as a tribal attorney, land defender and founder of the Giniw Collective during a special event at Dickinson College.
  • Her public talk will take place Wednesday, Oct. 4, at 7 p.m. in the college's Anita Tuvin Schlechter Auditorium.
  • Tara Houska has received The Sam Rose '58 & Julie Walters Prize for Global Environmental Activism at Dickinson College.
  • Houska is the 2023 recipient of The Sam Rose '58 and Julie Walters Prize for Global Environmental Activism at Dickinson College.

Global COVID-19 Sample Collection Kits Market Analysis Report 2023: Market Value is Set to Decline by Over 18% to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 3, 2023
Infectious Diseases, Health, COVID-19, U.S. Department of Defense Strategy for Operating in Cyberspace, HHS, Smartphone, SARS-CoV-2, Coronavirus, Office of Inspector General, U.S. Department of Health and Human Services, Roche, PCR, VTM, BD (company), Thermo Fisher Scientific, USD, Centers for Disease Control and Prevention, CDC, Dickinson, Hospital, Application, Organization, Puritan Medical Products, Site, Growth, Viral, WHO, FDA, Vaccine, Pharmaceutical industry, Medical device, Collection

The global COVID-19 sample collection kits market size is expected to reach USD 1.26 billion by 2030 but it is expected to decline at a CAGR of -18.27% from 2023 to 2030.

Key Points: 
  • The global COVID-19 sample collection kits market size is expected to reach USD 1.26 billion by 2030 but it is expected to decline at a CAGR of -18.27% from 2023 to 2030.
  • With the continuous approval of diagnostic tests for effective diagnoses of SARS-CoV-2 infection, the demand for sample collection products, including swabs and Viral Transport Media (VTM), has surged.
  • The shortage of testing materials such as swabs and reagents has led to the emergence of new players in the market, driving revenue growth.
  • Regulatory agencies have played a crucial role in propelling the market forward by ensuring product efficiency and expediting new approvals.

Caliber Expands its Internal Wholesale Team as the Firm Accelerates its Capital Markets Initiatives

Retrieved on: 
Monday, June 26, 2023
Asset Management, Professional Services, Finance, J. Rich Steers, Inc., CNL, Financial Planning Association of Australia, Legg Mason, Senior, NYSE Arca Major Market Index, RIA, Miami University, Commercial property, GE Capital, Business school, Garten, Nationwide Mutual Insurance Company, Lage, NYSE, Corporate development, University, Capital market, REIT, University of La Verne, Cohen, National accounts, Asset, Growth, Hill, Earl Jones (investment advisor), Apollo Global Management, GE, CCT, Bellevue University, Dickinson, Region, Registered investment adviser, Economics, University of Missouri–St. Louis, TSY, CREW, History and impact of institutional investment in housing in the United States, Jameson, Marketing, Sale, Apollo, Financial adviser, Management, Caliber

Caliber’s new wholesale team will report to Howard Hill, Senior Vice President of Corporate Development and Head of Capital Markets for Caliber.

Key Points: 
  • Caliber’s new wholesale team will report to Howard Hill, Senior Vice President of Corporate Development and Head of Capital Markets for Caliber.
  • Following the sale of Trustreet to GE Capital, he was named Vice President, Mid-Cap Markets for GE.
  • Before Griffin Capital, he held various capital markets positions at Cole Capital, including Senior Vice President of Major Markets in New York City.
  • Mark Dickinson, Vice President of Capital Markets – West, has been with Caliber since 2019 and recently joined this new wholesale team.

Environmental and Indigenous Rights Advocate to Receive Dickinson College's Rose-Walters Prize for Environmental Activism

Retrieved on: 
Tuesday, April 25, 2023
Couchiching First Nation, Barack Obama, All We Can Save, University, Dakota Access Pipeline, Policy, Tara Houska, Woman, Country, Movement, CNN, Houska, Organization, Dickinson, Native Americans, Publication, The New York Times, Dickinson College, Stop Line 3 protests, Empathy, Indian Country Today, TED, Jewellery

CARLISLE, Pa., April 25, 2023 /PRNewswire/ -- Tara Houska, a citizen of Couchiching First Nation and advocate for environmental and Indigenous rights, will receive The Sam Rose '58 and Julie Walters Prize for Global Environmental Activism at Dickinson College.

Key Points: 
  • CARLISLE, Pa., April 25, 2023 /PRNewswire/ -- Tara Houska, a citizen of Couchiching First Nation and advocate for environmental and Indigenous rights, will receive The Sam Rose '58 and Julie Walters Prize for Global Environmental Activism at Dickinson College.
  • This annual $100,000 prize is awarded to individuals or organizations significantly impacting responsible action for the planet, its resources, and its people.
  • Houska is a prominent opponent of the Line 3 and Dakota Access pipelines and plays an active role in the movement to defund fossil fuels.
  • The Rose-Walters Prize has previously honored climate advocates including Elizabeth Kolbert, Mark Ruffalo, Bill McKibben, and Lisa Jackson.

NDA Partners Appoints Former FDA Lead Reviewer in the Office of In Vitro Diagnostics, Dr. Cortez McBerry as Partner in the Firm

Retrieved on: 
Thursday, April 20, 2023
BS, De novo, CDRH, University, National Institute of Allergy and Infectious Diseases, Negotiation, Doctor of Philosophy, Bangladesh Technical Education Board, IDS, MS, Police, Dickinson, Molecular biology, Partner, Division, Immunology, NIAID, NIH, Infection, BD, Medical device, EU, Microbiology, Southern Illinois University

WASHINGTON, April 20, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Cortez McBerry, a former Lead Reviewer in the FDA Division of Immunology and Hematology Devices in the Office of In Vitro Diagnostics (CDRH), has been appointed as Partner in the firm. Dr. McBerry is an experienced diagnostics expert with extensive experience in regulatory strategy, regulatory affairs, labeling, and managing US, EU, and Notified Body regulatory submissions for medical devices, and in vitro and companion diagnostics.

Key Points: 
  • NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Cortez McBerry, a former Lead Reviewer in the FDA Division of Immunology and Hematology Devices in the Office of In Vitro Diagnostics (CDRH), has been appointed as Partner in the firm.
  • Dr. McBerry has worked with the firm since 2021 as Regulatory Consulting Director following his role as Senior Regulatory Affairs Manager at Becton, Dickinson, and Company (BD), Integrated Diagnostic Solutions (IDS).
  • WASHINGTON, April 20, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Cortez McBerry , a former Lead Reviewer in the FDA Division of Immunology and Hematology Devices in the Office of In Vitro Diagnostics (CDRH), has been appointed as Partner in the firm.
  • Dr. McBerry also served as Senior Regulatory Affairs Manager at Becton, Dickinson, and Company (BD), Integrated Diagnostic Solutions (IDS), in Baltimore, Maryland.

Cervical Dysplasia Market is expected to generate a revenue of USD 789.32 Million by 2030, Globally, at 7% CAGR: Verified Market Research®

Retrieved on: 
Monday, January 30, 2023
Conditional sentence, Dickinson, USD, Quest Diagnostics, Diagnosis, Midsayap Diagnostic Center and Hospital, Vulvectomy, Cervical intraepithelial neoplasia, Government, Minerva Surgical, Inc. v. Hologic, Inc., Drug combination, Woman, QIAGEN, Cancer, Geography, Cervical cancer, Hospital, Mortality, Test management, Research, Projection, Retail, Medical device, Birth control

JERSEY CITY, N.J. , Jan. 30, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Cervical Dysplasia Market" By Diagnostic (Diagnostic Tests, Diagnostic Devices), By End-User (Hospitals, Diagnostic Centers), and By Geography.

Key Points: 
  • JERSEY CITY, N.J. , Jan. 30, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, " Cervical Dysplasia Market " By Diagnostic (Diagnostic Tests, Diagnostic Devices), By End-User (Hospitals, Diagnostic Centers), and By Geography.
  • The "Global Cervical Dysplasia Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
  • The "Global Cervical Dysplasia Market" study report will provide valuable insight with an emphasis on the global market.
  • Ltd, OncoHealth Corporation, Inc., and Hologic, Inc.
    Based on the research, Verified Market Research® has segmented the global Cervical Dysplasia Market into Diagnostic, End-User, and Geography.

Cervical Dysplasia Market is expected to generate a revenue of USD 789.32 Million by 2030, Globally, at 7% CAGR: Verified Market Research®

Retrieved on: 
Monday, January 30, 2023
Conditional sentence, Dickinson, USD, Quest Diagnostics, Diagnosis, Midsayap Diagnostic Center and Hospital, Vulvectomy, Cervical intraepithelial neoplasia, Government, Minerva Surgical, Inc. v. Hologic, Inc., Drug combination, Woman, QIAGEN, Cancer, Geography, Cervical cancer, Hospital, Mortality, Test management, Research, Projection, Retail, Medical device, Birth control

JERSEY CITY, N.J., Jan. 30, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Cervical Dysplasia Market" By Diagnostic (Diagnostic Tests, Diagnostic Devices), By End-User (Hospitals, Diagnostic Centers), and By Geography.

Key Points: 
  • JERSEY CITY, N.J., Jan. 30, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, " Cervical Dysplasia Market " By Diagnostic (Diagnostic Tests, Diagnostic Devices), By End-User (Hospitals, Diagnostic Centers), and By Geography.
  • The "Global Cervical Dysplasia Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
  • The "Global Cervical Dysplasia Market" study report will provide valuable insight with an emphasis on the global market.
  • Ltd, OncoHealth Corporation, Inc., and Hologic, Inc.
    Based on the research, Verified Market Research® has segmented the global Cervical Dysplasia Market into Diagnostic, End-User, and Geography.